Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-18 · accession 0001468308-26-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-19 | 2026-02-18 | FENC | Andrade Robert | CFO | M - OptEx | $0.3362 | +29.7K | 215.1K | +16% | +$9,996 |
| D | 2026-02-19 | 2026-02-18 | FENC | Andrade Robert | CFO | M - OptEx | $4.08 | -2,450 | 814.1K | -0.3% | -$9,996 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2026-02-18 | M | A | 27,285 | $0.00 | 242,393 | D | — | — | (F2) Represents settlement of PSUs that vested on February 18, 2026. |
| 2 | Common | Common shares | 2026-02-18 | M | A | 2,450 | $4.08 | 215,108 | D | — | — | (F1) Shares acquired through the exercise of an option contract with strike price of $4.08 and an expiration date of December 20, 2031. |
| 3 | Derivative | Stock Options | 2026-02-18 | M | D | 2,450 | $4.08 | 814,117 | D | $4.08 · 2021-12-20 to 2031-12-20 | 2,450 Options | (F1) Shares acquired through the exercise of an option contract with strike price of $4.08 and an expiration date of December 20, 2031. |